- PrimeView
- Published:
Hepatocellular carcinoma
Nature Reviews Disease Primers volume 7, Article number: 7 (2021)
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
ZNF692 drives malignant development of hepatocellular carcinoma cells by promoting ALDOA-dependent glycolysis
Functional & Integrative Genomics Open Access 08 March 2024
-
The interaction between intratumoral bacteria and metabolic distortion in hepatocellular carcinoma
Journal of Translational Medicine Open Access 04 March 2024
-
Development of machine learning-based predictors for early diagnosis of hepatocellular carcinoma
Scientific Reports Open Access 04 March 2024
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 /Â 30Â days
cancel any time
Subscribe to this journal
Receive 1 digital issues and online access to articles
$99.00 per year
only $99.00 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
The incidence of Hepatocellular carcinoma (HCC) is increasing worldwide. This PrimeView describes the epidemiology, mechanisms and diagnosis of HCC as well as highlights the major advancements in its management.
Rights and permissions
About this article
Cite this article
Hepatocellular carcinoma. Nat Rev Dis Primers 7, 7 (2021). https://doi.org/10.1038/s41572-021-00245-6
Published:
DOI: https://doi.org/10.1038/s41572-021-00245-6